Covestor
EWTX icon

Covestor’s Edgewise Therapeutics EWTX Stock Holding History

Covestor’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$0 Sell
10
-11
-52% -$467 ﹤0.01% 2506
2026
Q2 		$1K Buy
21
+13
+163% +$448 ﹤0.01% 2141
2026
Q1 		$0 Hold
8
– – ﹤0.01% 2407
2025
Q4 		$0 Hold
8
– – ﹤0.01% 2393
2025
Q3 		$0 Hold
8
– – ﹤0.01% 2422
2025
Q2 		$0 Buy
8
+3
+60% +$43 ﹤0.01% 2360
2025
Q1 		$0 Hold
5
– – ﹤0.01% 2373
2024
Q4 		$0 Sell
5
-2
-29% -$64 ﹤0.01% 2382
2024
Q3 		$0 Hold
7
– – ﹤0.01% 2368
2024
Q2 		$0 Hold
7
– – ﹤0.01% 2382
2024
Q1 		$0 Buy
+7
New +$111 ﹤0.01% 2379

Other funds holding EWTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Covestor's EWTX Position: Q3 2026 in Review

Covestor reduced its Edgewise Therapeutics (EWTX) stake by 52% in Q3 2026, selling an estimated $467 and leaving 10 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2506.

Covestor first reported a position in EWTX in Q1 2024 and has held it in 11 quarters since. The position peaked at $1K in Q2 2026. 70 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.

  • Covestor held 10 shares of Edgewise Therapeutics worth $0 as of Q3 2026.
  • Covestor sold 11 Edgewise Therapeutics shares in Q3 2026, an estimated $467.
  • Edgewise Therapeutics made up ﹤0.01% of Covestor's portfolio in Q3 2026, its #2506 holding.
  • Covestor first reported a position in Edgewise Therapeutics in Q1 2024 and has held it in 11 quarters since.
  • Covestor's Edgewise Therapeutics position peaked at $1K in Q2 2026.
  • 70 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.